首页 > 最新文献

American journal of cardiovascular disease最新文献

英文 中文
Overcoming therapeutic challenges in a case of refractory chylothorax following blunt abdominal trauma through the utility of cone-beam computed tomography lymphangiography. 利用锥形束计算机断层淋巴管造影克服腹部钝性创伤后难治性乳糜胸一例的治疗挑战。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/QIEZ3054
Hasan Dinc, Sükrü Oguz, Selcuk Akkaya, Elif Merve Bal, Atilla Türkyılmaz, Bekir Sami Karapolat, Celal Tekinbaş

Chylothorax development following blunt abdominal trauma is a rare event. While low volume chylothoraxes usually improve with conservative treatment, invasive interventions are required in high-volume chylothoraxes with daily drainage exceeding 1000 ml. We report a case of a 14-year-old boy who developed high-volume (>3 L/d) chylothorax on the left side following blunt abdominal trauma. The patient did not respond to conservative treatments. He underwent thoracic duct ligation three times, with percutaneous lymphatic interventions, and percutaneous Lipiodol-glue mixture injections under computed tomography (CT) guidance, but all treatments were unsuccessful. We describe the four-month multidisciplinary challenge in this case that was ultimately successfully treated by surgical ligation of aberrant and/or collateral lymphatics draining from the left abdomen to the left pleural cavity, with the help of the novel cone-beam computed tomography (CBCT) lymphangiography (LAG) technique.

钝性腹部创伤后发展乳糜胸是一种罕见的事件。虽然小容量乳糜胸通常通过保守治疗得到改善,但对于每天引流超过1000毫升的大容量乳糜胸,需要进行侵入性干预。我们报告了一个14岁的男孩,他在钝性腹部创伤后出现了左侧大容量(bbb3l /d)乳糜胸。患者对保守治疗无反应。他接受了三次胸导管结扎术,经皮淋巴介入,并在计算机断层扫描(CT)指导下经皮注射脂醇-胶混合物,但所有治疗均不成功。我们描述了在这种情况下,四个月的多学科挑战,最终成功地通过手术结扎异常和/或侧支淋巴管从左腹部引流到左胸膜腔,在新型锥形束计算机断层扫描(CBCT)淋巴管造影(LAG)技术的帮助下。
{"title":"Overcoming therapeutic challenges in a case of refractory chylothorax following blunt abdominal trauma through the utility of cone-beam computed tomography lymphangiography.","authors":"Hasan Dinc, Sükrü Oguz, Selcuk Akkaya, Elif Merve Bal, Atilla Türkyılmaz, Bekir Sami Karapolat, Celal Tekinbaş","doi":"10.62347/QIEZ3054","DOIUrl":"10.62347/QIEZ3054","url":null,"abstract":"<p><p>Chylothorax development following blunt abdominal trauma is a rare event. While low volume chylothoraxes usually improve with conservative treatment, invasive interventions are required in high-volume chylothoraxes with daily drainage exceeding 1000 ml. We report a case of a 14-year-old boy who developed high-volume (>3 L/d) chylothorax on the left side following blunt abdominal trauma. The patient did not respond to conservative treatments. He underwent thoracic duct ligation three times, with percutaneous lymphatic interventions, and percutaneous Lipiodol-glue mixture injections under computed tomography (CT) guidance, but all treatments were unsuccessful. We describe the four-month multidisciplinary challenge in this case that was ultimately successfully treated by surgical ligation of aberrant and/or collateral lymphatics draining from the left abdomen to the left pleural cavity, with the help of the novel cone-beam computed tomography (CBCT) lymphangiography (LAG) technique.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"48-55"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and outcomes of patients undergoing percutaneous coronary intervention at Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia, 2024. 2024 年在埃塞俄比亚亚的斯亚贝巴 Gesund 心脏和医疗中心接受经皮冠状动脉介入治疗的患者的临床特征和疗效。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/RIAQ1956
Kesete Eskias, Alemayehu Bekele, Ousman Adal, Heyria Hussien, Lemlem Beza Demisse

Introduction: Percutaneous coronary intervention (PCI) is a critical procedure for improving blood flow by alleviating arterial blockage. However, its availability in Ethiopia is limited because of insufficient resources, staff, and infrastructure.

Objective: To evaluate the clinical characteristics and outcomes of patients who underwent percutaneous coronary intervention at Gesund Cardiac and Medical Center in Addis Ababa, Ethiopia, in 2024.

Methods: This retrospective observational chart review included 224 patients who underwent percutaneous coronary intervention. Data were collected using a standardized checklist, imported into EPI information v7, and analyzed using SPSS v26. A binary logistic regression model was used to identify factors associated with percutaneous coronary intervention.

Results: The study found that most participants (n = 186, 83%) were male, with a mean age of 57.82 ± 11.5 years. Diabetes mellitus was prevalent among participants (n = 135, 60.3%), followed by hypertension (n = 127, 56.7%). A notable portion (n = 31, 13.8%) had previously undergone percutaneous coronary intervention. Most patients presented with typical chest pain, with ST-Elevation Myocardial Infarction (STEMI) being the primary indication for percutaneous coronary intervention. Post-procedure complications includes significant bleeding (n = 6, 2.6%), myocardial infarction (n = 20, 8.9%), death (n = 2, 0.9%), transfer to another hospital (n = 12, 5.4%), and acute kidney injury (n = 16, 7.14%). The use of bare metal stents was significantly associated with transfer to other hospitals (AOR = 5; 95% CI = 1.69-10.29). Male gender (AOR = 0.09; 95% CI = 0.03-0.34) and a history of myocardial infarction (AOR = 10; 95% CI = 2.31-13.31) were linked to an increased risk of post-percutaneous coronary intervention death.

Conclusion and recommendations: Our findings suggest that coronary artery stenosis (CAS) is more prevalent in older individuals and men. Chronic illnesses often coexist with coronary artery stenosis, thereby complicating the prognosis. Interestingly, men exhibited a lower risk of unfavorable outcomes compared to women. Adherence to procedural guidelines and effective management techniques are essential for improving patient outcomes following percutaneous coronary intervention.

导读:经皮冠状动脉介入治疗(PCI)是通过缓解动脉阻塞来改善血液流动的关键手术。然而,由于资源、人员和基础设施不足,其在埃塞俄比亚的可用性有限。目的:评价2024年在埃塞俄比亚亚的斯亚贝巴Gesund心脏和医学中心接受经皮冠状动脉介入治疗的患者的临床特点和预后。方法:回顾性观察224例经皮冠状动脉介入治疗患者。使用标准化检查表收集数据,导入EPI信息v7,并使用SPSS v26进行分析。采用二元logistic回归模型确定与经皮冠状动脉介入治疗相关的因素。结果:研究发现,大多数参与者(n = 186, 83%)为男性,平均年龄57.82±11.5岁。糖尿病在参与者中最为普遍(n = 135, 60.3%),其次是高血压(n = 127, 56.7%)。相当一部分(n = 31, 13.8%)曾接受过经皮冠状动脉介入治疗。大多数患者表现为典型的胸痛,st段抬高型心肌梗死(STEMI)是经皮冠状动脉介入治疗的主要指征。术后并发症包括大出血(n = 6, 2.6%)、心肌梗死(n = 20, 8.9%)、死亡(n = 2, 0.9%)、转院(n = 12, 5.4%)和急性肾损伤(n = 16, 7.14%)。裸金属支架的使用与转院率显著相关(AOR = 5;95% ci = 1.69-10.29)。男性(AOR = 0.09;95% CI = 0.03-0.34)和心肌梗死史(AOR = 10;95% CI = 2.31-13.31)与经皮冠状动脉介入治疗后死亡风险增加有关。结论和建议:我们的研究结果表明冠状动脉狭窄(CAS)在老年人和男性中更为普遍。慢性疾病常与冠状动脉狭窄共存,从而使预后复杂化。有趣的是,与女性相比,男性表现出较低的不良结果风险。遵守手术指南和有效的管理技术对于改善经皮冠状动脉介入治疗后的患者预后至关重要。
{"title":"Clinical characteristics and outcomes of patients undergoing percutaneous coronary intervention at Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia, 2024.","authors":"Kesete Eskias, Alemayehu Bekele, Ousman Adal, Heyria Hussien, Lemlem Beza Demisse","doi":"10.62347/RIAQ1956","DOIUrl":"10.62347/RIAQ1956","url":null,"abstract":"<p><strong>Introduction: </strong>Percutaneous coronary intervention (PCI) is a critical procedure for improving blood flow by alleviating arterial blockage. However, its availability in Ethiopia is limited because of insufficient resources, staff, and infrastructure.</p><p><strong>Objective: </strong>To evaluate the clinical characteristics and outcomes of patients who underwent percutaneous coronary intervention at Gesund Cardiac and Medical Center in Addis Ababa, Ethiopia, in 2024.</p><p><strong>Methods: </strong>This retrospective observational chart review included 224 patients who underwent percutaneous coronary intervention. Data were collected using a standardized checklist, imported into EPI information v7, and analyzed using SPSS v26. A binary logistic regression model was used to identify factors associated with percutaneous coronary intervention.</p><p><strong>Results: </strong>The study found that most participants (n = 186, 83%) were male, with a mean age of 57.82 ± 11.5 years. Diabetes mellitus was prevalent among participants (n = 135, 60.3%), followed by hypertension (n = 127, 56.7%). A notable portion (n = 31, 13.8%) had previously undergone percutaneous coronary intervention. Most patients presented with typical chest pain, with ST-Elevation Myocardial Infarction (STEMI) being the primary indication for percutaneous coronary intervention. Post-procedure complications includes significant bleeding (n = 6, 2.6%), myocardial infarction (n = 20, 8.9%), death (n = 2, 0.9%), transfer to another hospital (n = 12, 5.4%), and acute kidney injury (n = 16, 7.14%). The use of bare metal stents was significantly associated with transfer to other hospitals (AOR = 5; 95% CI = 1.69-10.29). Male gender (AOR = 0.09; 95% CI = 0.03-0.34) and a history of myocardial infarction (AOR = 10; 95% CI = 2.31-13.31) were linked to an increased risk of post-percutaneous coronary intervention death.</p><p><strong>Conclusion and recommendations: </strong>Our findings suggest that coronary artery stenosis (CAS) is more prevalent in older individuals and men. Chronic illnesses often coexist with coronary artery stenosis, thereby complicating the prognosis. Interestingly, men exhibited a lower risk of unfavorable outcomes compared to women. Adherence to procedural guidelines and effective management techniques are essential for improving patient outcomes following percutaneous coronary intervention.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"29-38"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of threshold-loaded inspiratory muscle training and respiratory biofeedback on preserving inspiratory muscle strength and vital capacity after CABG: a randomized clinical trial. 阈值负荷的吸气肌训练和呼吸生物反馈对冠脉搭桥后保持吸气肌力量和肺活量的影响:一项随机临床试验。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/JBMU4830
Bahareh Mehregan-Far, Sedigheh Sadat Naimi, Mohsen Abedi, Parsa Salemi, Seyed Ahmad Raeis-Sadat, Mahmood Beheshti-Monfared

Objectives: Postoperative pulmonary complications (POPC) are common after cardiac surgeries such as coronary artery bypass grafting (CABG) and are influenced by factors including anesthesia and surgical trauma. Inspiratory muscle training (IMT) with visual biofeedback may mitigate these complications. This study investigates the impact of threshold loading inspiratory muscle training (TL-IMT) combined with respiratory biofeedback on the dynamic strength of inspiratory muscles (S-index) in patients undergoing CABG surgery during their hospitalization phase.

Methods: A single-blind study was conducted with 38 CABG candidates at Shahid Modares Hospital, Tehran. Participants were randomized into two groups: the TL-IMT with biofeedback group and the placebo IMT group. TL-IMT exercises were performed at 30% of maximum dynamic inspiratory strength using the Power Breath K5 device, with visual biofeedback displayed on the screen. The placebo group performed the same exercises at minimal load without biofeedback. Both groups received standard respiratory physiotherapy. Measurements of S-index, peak inspiratory flow (PIF), and vital capacity (VC) were taken before surgery (T1), one day after surgery (T2), and at discharge (T3).

Results: Both groups showed significant changes, with a decrease from T1 to T2 and an increase from T2 to T3. In the study group, T3 values remained the same as at T1, while the placebo IMT group experienced a significant decrease. After surgery, both groups had a drop in the S-index. However, the study group saw more pronounced changes between T3-T2 and T3-T1 compared to the control group, although no significant difference was found between T2-T1. By the time of discharge, the TL-IMT group had higher S-index values than the placebo group, returning to preoperative levels. Additionally, the TL-IMT group showed improvements in PIF and VC.

Conclusion: TL-IMT with visual biofeedback effectively maintains dynamic inspiratory muscle strength and improves key pulmonary parameters in cardiac surgery patients. These findings suggest that integrating TL-IMT with biofeedback can enhance postoperative recovery and reduce the incidence of POPC.

目的:术后肺部并发症(POPC)是冠状动脉旁路移植术(CABG)等心脏手术后常见的并发症,受麻醉和手术创伤等因素的影响。吸气肌训练(IMT)与视觉生物反馈可以减轻这些并发症。本研究探讨阈值负荷吸气肌训练(TL-IMT)结合呼吸生物反馈对冠脉搭桥患者住院期吸气肌动态强度(s指数)的影响。方法:对德黑兰Shahid Modares医院的38例CABG候选者进行单盲研究。参与者被随机分为两组:生物反馈的TL-IMT组和安慰剂IMT组。使用Power Breath K5装置以最大动态吸气强度的30%进行TL-IMT练习,并在屏幕上显示视觉生物反馈。安慰剂组在没有生物反馈的情况下以最小负荷进行相同的锻炼。两组均接受标准的呼吸物理治疗。术前(T1)、术后1天(T2)和出院时(T3)分别测定s指数、吸气峰值流量(PIF)和肺活量(VC)。结果:两组均有明显变化,T1 - T2降低,T2 - T3升高。在研究组中,T3值与T1时相同,而安慰剂IMT组T3值明显下降。术后两组患者s指数均有下降。与对照组相比,研究组T3-T2和T3-T1的变化更为明显,但T2-T1之间无明显差异。出院时,TL-IMT组s指数高于安慰剂组,恢复到术前水平。此外,TL-IMT组在PIF和VC方面也有改善。结论:视觉生物反馈TL-IMT能有效维持心脏手术患者动态吸气肌力量,改善肺关键参数。这些结果表明,将TL-IMT与生物反馈相结合可以提高术后恢复,减少POPC的发生率。
{"title":"The impact of threshold-loaded inspiratory muscle training and respiratory biofeedback on preserving inspiratory muscle strength and vital capacity after CABG: a randomized clinical trial.","authors":"Bahareh Mehregan-Far, Sedigheh Sadat Naimi, Mohsen Abedi, Parsa Salemi, Seyed Ahmad Raeis-Sadat, Mahmood Beheshti-Monfared","doi":"10.62347/JBMU4830","DOIUrl":"10.62347/JBMU4830","url":null,"abstract":"<p><strong>Objectives: </strong>Postoperative pulmonary complications (POPC) are common after cardiac surgeries such as coronary artery bypass grafting (CABG) and are influenced by factors including anesthesia and surgical trauma. Inspiratory muscle training (IMT) with visual biofeedback may mitigate these complications. This study investigates the impact of threshold loading inspiratory muscle training (TL-IMT) combined with respiratory biofeedback on the dynamic strength of inspiratory muscles (S-index) in patients undergoing CABG surgery during their hospitalization phase.</p><p><strong>Methods: </strong>A single-blind study was conducted with 38 CABG candidates at Shahid Modares Hospital, Tehran. Participants were randomized into two groups: the TL-IMT with biofeedback group and the placebo IMT group. TL-IMT exercises were performed at 30% of maximum dynamic inspiratory strength using the Power Breath K5 device, with visual biofeedback displayed on the screen. The placebo group performed the same exercises at minimal load without biofeedback. Both groups received standard respiratory physiotherapy. Measurements of S-index, peak inspiratory flow (PIF), and vital capacity (VC) were taken before surgery (T1), one day after surgery (T2), and at discharge (T3).</p><p><strong>Results: </strong>Both groups showed significant changes, with a decrease from T1 to T2 and an increase from T2 to T3. In the study group, T3 values remained the same as at T1, while the placebo IMT group experienced a significant decrease. After surgery, both groups had a drop in the S-index. However, the study group saw more pronounced changes between T3-T2 and T3-T1 compared to the control group, although no significant difference was found between T2-T1. By the time of discharge, the TL-IMT group had higher S-index values than the placebo group, returning to preoperative levels. Additionally, the TL-IMT group showed improvements in PIF and VC.</p><p><strong>Conclusion: </strong>TL-IMT with visual biofeedback effectively maintains dynamic inspiratory muscle strength and improves key pulmonary parameters in cardiac surgery patients. These findings suggest that integrating TL-IMT with biofeedback can enhance postoperative recovery and reduce the incidence of POPC.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"375-383"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Movahed protocol and algorithm for preventing intubation in patients with acute or sympathetic crashing acute pulmonary edema (SCAPE) without cardiogenic shock by repeated administration of buccal nitroglycerin ointments. 反复给予口腔硝酸甘油软膏防止急性或交感性急性肺水肿(SCAPE)无心源性休克患者插管的Movahed方案和算法。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/CXMD7229
Mohammad Reza Movahed

Patients presenting with severe acute cardiogenic pulmonary edema with hypoxia commonly require intubation until heart failure treatments take effect. A new term describing similar condition is called sympathetic crashing acute pulmonary edema (SCAPE). It is also called Flash pulmonary edema. Immediate pre- and afterload reduction can abort intubation. Using rapid repeated buccal administrations of nitroglycerin ointments can prevent intubation by rapidly reducing pre- and afterload as long as systolic blood pressure remains adequate without cardiogenic shock. A case series of 6 patients who needed intubation due to severe cardiogenic pulmonary edema and hypoxia despite 100% O2 administration without the presence of cardiogenic shock were successfully treated with repeated buccal administration of nitroglycerin ointments. Approximately half of an inch of nitroglycerin ointment (nitropaste) was buccally administrated every 60 seconds as long as repeated blood pressure measurements every minute before each repeated administration remained above 120 mmHg. Complete response with resolution of dyspnea with minimal oxygen requirement achieved in less than 30 minutes in all patients. Intubation was prevented in all 6 patients. No adverse events occurred in any of the patients. A treatment protocol and algorithm are developed based on these patients and reported cases in the literature for prevention of intubation in these patients. Rapid repeated buccal administration of nitroglycerin ointment is highly effective in preventing intubation and mechanical ventilation in patients with any acute pulmonary edema or SCAPE and hypoxia without cardiogenic shock.

出现严重急性心源性肺水肿并缺氧的患者通常需要插管,直到心力衰竭治疗生效。描述类似情况的一个新术语称为交感冲击急性肺水肿(SCAPE)。也叫闪发性肺水肿。立即的术前和术后负荷减少会导致插管失败。只要收缩压保持适当且无心源性休克,使用快速反复的口腔给药硝酸甘油软膏可以通过快速降低前负荷和后负荷来防止插管。本文报道了6例因严重心源性肺水肿和缺氧而需要插管的患者,尽管给予100%的氧气,但没有心源性休克,我们成功地通过反复口腔给药硝酸甘油软膏治疗。只要每次重复给药前每分钟重复一次血压测量保持在120 mmHg以上,每60秒口腔给药大约半英寸的硝酸甘油软膏(硝化膏)。所有患者均在30分钟内完全缓解呼吸困难,需氧量最低。6例患者均未插管。所有患者均未发生不良事件。根据这些患者和文献中报道的病例,制定了预防这些患者插管的治疗方案和算法。快速反复口腔给药硝酸甘油软膏对无心源性休克的急性肺水肿或急性肺水肿及缺氧患者预防插管和机械通气非常有效。
{"title":"The Movahed protocol and algorithm for preventing intubation in patients with acute or sympathetic crashing acute pulmonary edema (SCAPE) without cardiogenic shock by repeated administration of buccal nitroglycerin ointments.","authors":"Mohammad Reza Movahed","doi":"10.62347/CXMD7229","DOIUrl":"10.62347/CXMD7229","url":null,"abstract":"<p><p>Patients presenting with severe acute cardiogenic pulmonary edema with hypoxia commonly require intubation until heart failure treatments take effect. A new term describing similar condition is called sympathetic crashing acute pulmonary edema (SCAPE). It is also called Flash pulmonary edema. Immediate pre- and afterload reduction can abort intubation. Using rapid repeated buccal administrations of nitroglycerin ointments can prevent intubation by rapidly reducing pre- and afterload as long as systolic blood pressure remains adequate without cardiogenic shock. A case series of 6 patients who needed intubation due to severe cardiogenic pulmonary edema and hypoxia despite 100% O2 administration without the presence of cardiogenic shock were successfully treated with repeated buccal administration of nitroglycerin ointments. Approximately half of an inch of nitroglycerin ointment (nitropaste) was buccally administrated every 60 seconds as long as repeated blood pressure measurements every minute before each repeated administration remained above 120 mmHg. Complete response with resolution of dyspnea with minimal oxygen requirement achieved in less than 30 minutes in all patients. Intubation was prevented in all 6 patients. No adverse events occurred in any of the patients. A treatment protocol and algorithm are developed based on these patients and reported cases in the literature for prevention of intubation in these patients. Rapid repeated buccal administration of nitroglycerin ointment is highly effective in preventing intubation and mechanical ventilation in patients with any acute pulmonary edema or SCAPE and hypoxia without cardiogenic shock.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"368-374"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sertraline in depressed patients with or at risk for coronary heart disese: a systemic review. 舍曲林在伴有或有冠心病风险的抑郁症患者中的应用:一项系统综述。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/AXZC9187
Kiana Seifouri, Reza Kahdemi, Fatemeh Ahmadi Hajikolaei, Fatemeh Rasekh, Fariba Azadikhah, Ida Mehraban, Reyhaneh Alikhani, Alireza Mirjalili, Milad Alipour, Sayedeh-Fatemeh Sadat-Madani, Fatemeh Chichagi, Saeed Zivari Lashkajani, Amir Abdi, Mohaddeseh Belbasi, Ata Akhtari Kohnehshahri, Niloofar Deravi, Mahdyieh Naziri, Yasamin Pishkari, Melika Arab Bafrani, Vahid Aghsaghloo, Ali Faghih Habibi

Background and aims: Depression is a prevalent comorbidity among patients with coronary heart disease (CHD). While recent studies have hinted at a possible association between CHD and antidepressant medications like sertraline, the existing evidence remains inconclusive. To investigate this potential link, we conducted a comprehensive systematic review.

Methods: We systematically searched PubMed, Google Scholar, and Scopus for relevant articles published up to March 2023. After a thorough screening of titles and abstracts, 12 studies were included in our review.

Results: The included studies, spanning from 1999 to 2021, comprised 11 randomized controlled trials (RCTs) and one pilot study. A total of 2767 participants with major depressive disorder and a history of cardiovascular disease or at risk for such events were included. The majority of these studies demonstrated improvements in mood status among patients treated with serotonin-targeting antidepressants and a reduced risk of cardiovascular events, as measured by various outcomes. While some cardiac adverse effects were observed with serotonin treatment, these did not reach statistical significance.

Conclusion: Our findings provide evidence supporting the beneficial effects of serotonin-targeting antidepressants for both depressive symptoms and the prevention of coronary adverse outcomes. These results highlight the potential value of serotonin-based treatments for depression in high-risk populations.

背景与目的:抑郁症是冠心病(CHD)患者的常见合并症。虽然最近的研究暗示了冠心病与舍曲林等抗抑郁药物之间的可能联系,但现有的证据仍然没有定论。为了调查这种潜在的联系,我们进行了一项全面的系统综述。方法:系统检索PubMed、谷歌Scholar和Scopus,检索截止到2023年3月发表的相关文章。在对题目和摘要进行全面筛选后,我们的综述纳入了12项研究。结果:纳入的研究时间跨度为1999年至2021年,包括11项随机对照试验(rct)和1项试点研究。共有2767名患有重度抑郁症、有心血管疾病史或有此类事件风险的参与者被纳入研究。这些研究中的大多数表明,在接受以血清素为目标的抗抑郁药治疗的患者中,情绪状态有所改善,心血管事件的风险降低,这是通过各种结果来衡量的。虽然观察到一些心脏不良反应与血清素治疗,这些没有达到统计学意义。结论:我们的研究结果为血清素靶向抗抑郁药对抑郁症状和预防冠状动脉不良后果的有益作用提供了证据。这些结果突出了以血清素为基础的治疗高危人群抑郁症的潜在价值。
{"title":"Sertraline in depressed patients with or at risk for coronary heart disese: a systemic review.","authors":"Kiana Seifouri, Reza Kahdemi, Fatemeh Ahmadi Hajikolaei, Fatemeh Rasekh, Fariba Azadikhah, Ida Mehraban, Reyhaneh Alikhani, Alireza Mirjalili, Milad Alipour, Sayedeh-Fatemeh Sadat-Madani, Fatemeh Chichagi, Saeed Zivari Lashkajani, Amir Abdi, Mohaddeseh Belbasi, Ata Akhtari Kohnehshahri, Niloofar Deravi, Mahdyieh Naziri, Yasamin Pishkari, Melika Arab Bafrani, Vahid Aghsaghloo, Ali Faghih Habibi","doi":"10.62347/AXZC9187","DOIUrl":"10.62347/AXZC9187","url":null,"abstract":"<p><strong>Background and aims: </strong>Depression is a prevalent comorbidity among patients with coronary heart disease (CHD). While recent studies have hinted at a possible association between CHD and antidepressant medications like sertraline, the existing evidence remains inconclusive. To investigate this potential link, we conducted a comprehensive systematic review.</p><p><strong>Methods: </strong>We systematically searched PubMed, Google Scholar, and Scopus for relevant articles published up to March 2023. After a thorough screening of titles and abstracts, 12 studies were included in our review.</p><p><strong>Results: </strong>The included studies, spanning from 1999 to 2021, comprised 11 randomized controlled trials (RCTs) and one pilot study. A total of 2767 participants with major depressive disorder and a history of cardiovascular disease or at risk for such events were included. The majority of these studies demonstrated improvements in mood status among patients treated with serotonin-targeting antidepressants and a reduced risk of cardiovascular events, as measured by various outcomes. While some cardiac adverse effects were observed with serotonin treatment, these did not reach statistical significance.</p><p><strong>Conclusion: </strong>Our findings provide evidence supporting the beneficial effects of serotonin-targeting antidepressants for both depressive symptoms and the prevention of coronary adverse outcomes. These results highlight the potential value of serotonin-based treatments for depression in high-risk populations.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"318-329"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical cardiac rehabilitation effects on cardio-metabolic outcomes in the patients with hypertrophic cardiomyopathy: a systematic review. 心脏物理康复对肥厚性心肌病患者心脏代谢结局的影响:一项系统综述。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/JOYM3506
Fatemeh Chichagi, Kimiya Ghanbari-Mardasi, Niyousha Shirsalimi, Mahboobeh Sheikh, Diaa Hakim

Objectives: This systematic review aimed to review existing evidence to evaluate the effects of physical cardiac rehabilitation on cardio-pulmonary outcomes in the patients with hypertrophic cardiomyopathy (HCM).

Methods: We conducted a systematic search of the databases PubMed, Web of Science, Embase, Scopus, and Google Scholar. The initial search led to 1222 citations after removing duplicate results. We included only English-written studies published since 2013 (2013-2023). Ultimately, we retrieved five studies, involving 235 participants. We used the Cochrane Risk of Bias Tool for randomized trials (RoB2) and risk of bias in non-randomized studies of intervention (ROBINS-I) for evaluating the risk of bias in randomized and non-randomized studies, respectively.

Results: Results showed that four training programs improved participants' functional capacity by up to 46%. Improvements in weight, BMI, echocardiography, and remodeling parameters (left atrium volume index, premature ventricular contraction burden, pulmonary artery systolic pressure), exercise test results (minute ventilation/carbon dioxide production, peak workload, heart rate reserve, exercise duration, peak heart rate, peak systolic pressure, and blood pressure response to exercise normalization), and a decrease in N- Terminal Pro-Brain Natriuretic Peptide (NT-pro BNP) were reported in these studies. No major adverse events, including sustained tachyarrhythmia, implantable cardioverter-defibrillator discharge, and sudden cardiac death were reported.

Conclusion: Supervised exercise training is safe and helpful for patients diagnosed with HCM. It can improve exercise capacity and is considered an adjunctive therapeutic option.

目的:本系统综述旨在回顾现有证据,以评估心脏物理康复对肥厚性心肌病(HCM)患者心肺预后的影响。方法:系统检索PubMed、Web of Science、Embase、Scopus、谷歌Scholar等数据库。在删除重复结果后,最初的搜索导致1222次引用。我们只纳入了2013年(2013-2023年)以来发表的英语写作研究。最终,我们检索了5项研究,涉及235名参与者。我们分别使用Cochrane随机试验偏倚风险工具(RoB2)和非随机干预研究偏倚风险工具(ROBINS-I)来评估随机和非随机研究的偏倚风险。结果:结果表明,四种训练方案提高了参与者的功能能力高达46%。改善体重、BMI、超声心动图和重塑参数(左心房容积指数、室性早搏负荷、肺动脉收缩压)、运动试验结果(分钟通气量/二氧化碳生成、峰值负荷、心率储备、运动持续时间、心率峰值、收缩压峰值和血压对运动正常化的反应);这些研究报道了N端原脑钠肽(NT-pro BNP)的减少。无重大不良事件,包括持续的心动过速、植入式心律转复除颤器放电和心源性猝死。结论:有监督的运动训练对HCM患者是安全有益的。它可以提高运动能力,被认为是一种辅助治疗选择。
{"title":"Physical cardiac rehabilitation effects on cardio-metabolic outcomes in the patients with hypertrophic cardiomyopathy: a systematic review.","authors":"Fatemeh Chichagi, Kimiya Ghanbari-Mardasi, Niyousha Shirsalimi, Mahboobeh Sheikh, Diaa Hakim","doi":"10.62347/JOYM3506","DOIUrl":"10.62347/JOYM3506","url":null,"abstract":"<p><strong>Objectives: </strong>This systematic review aimed to review existing evidence to evaluate the effects of physical cardiac rehabilitation on cardio-pulmonary outcomes in the patients with hypertrophic cardiomyopathy (HCM).</p><p><strong>Methods: </strong>We conducted a systematic search of the databases PubMed, Web of Science, Embase, Scopus, and Google Scholar. The initial search led to 1222 citations after removing duplicate results. We included only English-written studies published since 2013 (2013-2023). Ultimately, we retrieved five studies, involving 235 participants. We used the Cochrane Risk of Bias Tool for randomized trials (RoB2) and risk of bias in non-randomized studies of intervention (ROBINS-I) for evaluating the risk of bias in randomized and non-randomized studies, respectively.</p><p><strong>Results: </strong>Results showed that four training programs improved participants' functional capacity by up to 46%. Improvements in weight, BMI, echocardiography, and remodeling parameters (left atrium volume index, premature ventricular contraction burden, pulmonary artery systolic pressure), exercise test results (minute ventilation/carbon dioxide production, peak workload, heart rate reserve, exercise duration, peak heart rate, peak systolic pressure, and blood pressure response to exercise normalization), and a decrease in N- Terminal Pro-Brain Natriuretic Peptide (NT-pro BNP) were reported in these studies. No major adverse events, including sustained tachyarrhythmia, implantable cardioverter-defibrillator discharge, and sudden cardiac death were reported.</p><p><strong>Conclusion: </strong>Supervised exercise training is safe and helpful for patients diagnosed with HCM. It can improve exercise capacity and is considered an adjunctive therapeutic option.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"330-341"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The influence of SGLT-2 inhibitors on lipid profiles in heart failure patients: a systematic review and meta-analysis. SGLT-2抑制剂对心力衰竭患者脂质谱的影响:系统回顾和荟萃分析
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/AAPZ2726
Seyed Mohammad Mahdi Meybodi, Mohammad Amin Karimi, Kourosh Mousazadeh, Kamyar Khorsand, Samira Masoumi, Seyed Abbas Pakmehr, Mahsa Asadi Anar, Nahid Samadi, Mohadeseh Poudineh, Mohammad Rahmanian, Shirin Yaghoobpoor, Arash Rahimi, Fariba Arbab Mojeni, Seyedeh Zahra Banihashemian, Mina Masoodi, Komeil Aghazadeh-Habashi, Atousa Ghorbani, Arezoo Faridzadeh, Niloofar Deravi

Background and aim: Sodium-glucose cotransporter two inhibitors can reduce cardiovascular events by modulating lipid profiles in patients with heart failure, irrespective of diabetes status. In this study, we aimed to assess the effects of SGLT-2 inhibitors on the lipid profiles of patients with heart failure via a meta-analysis.

Methods: The PubMed, Scopus, Web of Science, and Google Scholar databases were searched up to 2023 to retrieve relevant article titles, abstracts, and full texts. STATA software was used to conduct the meta-analysis.

Result: The Forest plot of fasting blood sugar levels in patients receiving SGLT-2 inhibitors differed significantly from those the in control group (mean difference = -0.08, 95% CI [-0.13, -0.02], P < 0.05). Analysis of lipid profile parameters, including total cholesterol, triglyceride, HDL, and LDL in patients with HF receiving SGLT-2 inhibitors, did not show a notable difference from the control group (P > 0.005). However, the mean difference was towards the reduction of LDL, cholesterol, and triglycerides and showed an increase in HDL levels. Egger's test for publication bias revealed some publication bias (P < 0.05).

Conclusion: Our topic analysis did not reveal any notable alterations in the lipid profile. To arrive at a more definite agreement, further research on subjects with heart failure is necessary because there is currently insufficient evidence.

背景和目的:钠-葡萄糖共转运蛋白2抑制剂可以通过调节心力衰竭患者的脂质谱来减少心血管事件,而与糖尿病状态无关。在这项研究中,我们旨在通过荟萃分析评估SGLT-2抑制剂对心力衰竭患者脂质谱的影响。方法:检索截至2023年的PubMed、Scopus、Web of Science和谷歌Scholar数据库,检索相关文章标题、摘要和全文。采用STATA软件进行meta分析。结果:SGLT-2抑制剂组空腹血糖Forest图与对照组有显著差异(平均差异= -0.08,95% CI [-0.13, -0.02], P < 0.05)。接受SGLT-2抑制剂的HF患者的血脂参数分析,包括总胆固醇、甘油三酯、HDL和LDL,与对照组没有显着差异(P < 0.05)。然而,平均差异是低密度脂蛋白、胆固醇和甘油三酯的降低,高密度脂蛋白水平升高。Egger's发表偏倚检验显示有一定的发表偏倚(P < 0.05)。结论:我们的主题分析没有发现任何显著的血脂变化。为了达成更明确的共识,有必要对心力衰竭患者进行进一步的研究,因为目前证据不足。
{"title":"The influence of SGLT-2 inhibitors on lipid profiles in heart failure patients: a systematic review and meta-analysis.","authors":"Seyed Mohammad Mahdi Meybodi, Mohammad Amin Karimi, Kourosh Mousazadeh, Kamyar Khorsand, Samira Masoumi, Seyed Abbas Pakmehr, Mahsa Asadi Anar, Nahid Samadi, Mohadeseh Poudineh, Mohammad Rahmanian, Shirin Yaghoobpoor, Arash Rahimi, Fariba Arbab Mojeni, Seyedeh Zahra Banihashemian, Mina Masoodi, Komeil Aghazadeh-Habashi, Atousa Ghorbani, Arezoo Faridzadeh, Niloofar Deravi","doi":"10.62347/AAPZ2726","DOIUrl":"10.62347/AAPZ2726","url":null,"abstract":"<p><strong>Background and aim: </strong>Sodium-glucose cotransporter two inhibitors can reduce cardiovascular events by modulating lipid profiles in patients with heart failure, irrespective of diabetes status. In this study, we aimed to assess the effects of SGLT-2 inhibitors on the lipid profiles of patients with heart failure via a meta-analysis.</p><p><strong>Methods: </strong>The PubMed, Scopus, Web of Science, and Google Scholar databases were searched up to 2023 to retrieve relevant article titles, abstracts, and full texts. STATA software was used to conduct the meta-analysis.</p><p><strong>Result: </strong>The Forest plot of fasting blood sugar levels in patients receiving SGLT-2 inhibitors differed significantly from those the in control group (mean difference = -0.08, 95% CI [-0.13, -0.02], P < 0.05). Analysis of lipid profile parameters, including total cholesterol, triglyceride, HDL, and LDL in patients with HF receiving SGLT-2 inhibitors, did not show a notable difference from the control group (P > 0.005). However, the mean difference was towards the reduction of LDL, cholesterol, and triglycerides and showed an increase in HDL levels. Egger's test for publication bias revealed some publication bias (P < 0.05).</p><p><strong>Conclusion: </strong>Our topic analysis did not reveal any notable alterations in the lipid profile. To arrive at a more definite agreement, further research on subjects with heart failure is necessary because there is currently insufficient evidence.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"295-305"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of high-intensity interval training and moderate-intensity continuous training on patients underwent Coronary Artery Bypass Graft surgery; a systematic review. 高强度间歇训练和中强度持续训练对冠状动脉搭桥术患者的影响系统回顾。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/EWMH1925
Fatemeh Chichagi, Reyhaneh Alikhani, Mohammad Hossein Hosseini, Kiarash Azadi, Niyousha Shirsalimi, Saeed Ghodsi, Mana Jameie

Objectives: To our knowledge, there is no clear consensus on a definitive cardiac rehabilitation method for patients undergoing Coronary Artery Bypass Graft (CABG). We conducted this systematic review to compare and evaluate the effects of two of the most frequent cardiac rehabilitation modalities, high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT), on cardiopulmonary variables.

Methods: We carried out a systematic search of the databases PubMed, Web of Science, Embase, Scopus, and Google Scholar. Following the removal of duplicate results, the original search yielded 385 citations. We identified four randomized clinical trials after reviewing titles, abstracts, and potential full-text studies. We utilized the Cochrane Risk of Bias Tool (RoB2) to assess the risk of bias.

Results: We included four randomized clinical trials involving 143 people. All trials included individuals who had CABG and completed HIIT or MICT sessions for at least four weeks. The findings indicated that HIIT programs may improve functional capacity, heart rate variability indices, and blood pressure management while lowering brain natriuretic peptide (BNP1-32) and N-terminal pro-b-type natriuretic peptide (NT-proBNP1-76) levels.

Conclusion: Given the findings, it appeared that supervised high-intensity exercise regimens could be more useful to patients. Following the surgery, HIIT therapy improves exercise capacity, the autonomic nervous system, volume overload, and blood pressure regulation.

目的:据我们所知,对于冠状动脉旁路移植术(CABG)患者的心脏康复方法尚无明确的共识。我们进行了这一系统综述,以比较和评估两种最常见的心脏康复方式,高强度间歇训练(HIIT)和中等强度连续训练(MICT)对心肺变量的影响。方法:系统检索PubMed、Web of Science、Embase、Scopus、谷歌Scholar等数据库。在删除重复结果之后,原始搜索产生了385次引用。在回顾了题目、摘要和潜在的全文研究后,我们确定了四项随机临床试验。我们使用Cochrane风险偏倚工具(RoB2)来评估偏倚风险。结果:我们纳入了四项随机临床试验,涉及143人。所有的试验都包括CABG和完成HIIT或MICT至少四周的个体。研究结果表明,HIIT方案可以改善功能能力、心率变异性指标和血压管理,同时降低脑钠肽(BNP1-32)和n端前b型钠肽(NT-proBNP1-76)水平。结论:鉴于这些发现,似乎有监督的高强度运动方案对患者更有用。手术后,HIIT治疗可改善运动能力、自主神经系统、容量过载和血压调节。
{"title":"The effects of high-intensity interval training and moderate-intensity continuous training on patients underwent Coronary Artery Bypass Graft surgery; a systematic review.","authors":"Fatemeh Chichagi, Reyhaneh Alikhani, Mohammad Hossein Hosseini, Kiarash Azadi, Niyousha Shirsalimi, Saeed Ghodsi, Mana Jameie","doi":"10.62347/EWMH1925","DOIUrl":"10.62347/EWMH1925","url":null,"abstract":"<p><strong>Objectives: </strong>To our knowledge, there is no clear consensus on a definitive cardiac rehabilitation method for patients undergoing Coronary Artery Bypass Graft (CABG). We conducted this systematic review to compare and evaluate the effects of two of the most frequent cardiac rehabilitation modalities, high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT), on cardiopulmonary variables.</p><p><strong>Methods: </strong>We carried out a systematic search of the databases PubMed, Web of Science, Embase, Scopus, and Google Scholar. Following the removal of duplicate results, the original search yielded 385 citations. We identified four randomized clinical trials after reviewing titles, abstracts, and potential full-text studies. We utilized the Cochrane Risk of Bias Tool (RoB2) to assess the risk of bias.</p><p><strong>Results: </strong>We included four randomized clinical trials involving 143 people. All trials included individuals who had CABG and completed HIIT or MICT sessions for at least four weeks. The findings indicated that HIIT programs may improve functional capacity, heart rate variability indices, and blood pressure management while lowering brain natriuretic peptide (BNP<sub>1-32</sub>) and N-terminal pro-b-type natriuretic peptide (NT-proBNP<sub>1-76</sub>) levels.</p><p><strong>Conclusion: </strong>Given the findings, it appeared that supervised high-intensity exercise regimens could be more useful to patients. Following the surgery, HIIT therapy improves exercise capacity, the autonomic nervous system, volume overload, and blood pressure regulation.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"306-317"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden and predictors of mortality related to cardiogenic shock in the South Bronx Population. 南布朗克斯人群与心源性休克相关的负担和死亡率预测因素。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/HYCA6457
Nismat Javed, Vikram Itare, Sai Vishnu Vardhan Allu, Shalini Penikilapate, Neelanjana Pandey, Nisha Ali, Preeti Jadhav, Sridhar Chilimuri, Jonathan N Bella

Objectives: Cardiogenic shock is a significant economic burden on healthcare facilities and patients. The prevalence and outcome of cardiogenic shock in the South Bronx are unknown. The aim of the study was to examine the burden of non-AMI CS in Hispanic and Black population in South Bronx and characterize their in-hospital outcomes.

Methods: We reviewed patient charts between 1/1/2022 and 1/1/2023 to identify patients with a primary diagnosis of cardiogenic shock (ICD codes R57.0, R57, R57.8, R57.9) residing in the following zip codes: 10451-59 and 10463. Student's T-test was used to assess differences for continuous variables; chi-square statistic was used for categorical variables. A logistic regression analysis model was used to assess independent predictors of mortality. A P-value of < 0.05 was considered significant.

Results: 87 patients were admitted with cardiogenic shock (60% African American, 67% male, mean age =62±15 years) of which 54 patients (62%) died. Those who died were older, had > 1 pressor, out-of-hospital arrest, arrested within 24 hours of admission, and had higher SCAI class, lactate, and ALT levels than those who were discharged. The logistic regression analysis model showed that older age ((RR=3.4 [95% CI: 3.3-3.45]), > 1 pressor (RR=3.4 [95% CI: 2.6-4.2]) and higher SCAI class (2.1 [95% CI: 1.5-2.1], all P < 0.05)) were independent predictors of mortality in patients with cardiogenic shock. Additionally, most of the patients had either Medicare or Medicaid insurance in predominantly African American study population.

Conclusions: Cardiogenic shock carries a significant risk of death. Factors such as advanced age, the administration of more than one vasopressor, and a higher SCAI classification have been identified as independent predictors of mortality among inpatients with cardiogenic shock. Additionally, the progression and outcomes of the condition are influenced by variables like race (e.g., African American individuals in this study) and economic challenges, including the type of insurance coverage (e.g., Medicaid or Medicare). Further research is essential to explore strategies that could enhance survival rates in cardiogenic shock patients, with a particular focus on addressing economic and racial disparities.

目的:心源性休克是医疗机构和患者的重大经济负担。在南布朗克斯,心源性休克的患病率和结果尚不清楚。该研究的目的是检查南布朗克斯西班牙裔和黑人人群的非ami CS负担,并描述他们的住院结果。方法:我们回顾了2022年1月1日至2023年1月1日期间的患者图表,以确定居住在以下邮政编码:10451-59和10463的初步诊断为心源性休克(ICD代码R57.0, R57, R57.8, R57.9)的患者。使用学生t检验来评估连续变量的差异;分类变量采用卡方统计。采用logistic回归分析模型评估死亡率的独立预测因子。p值< 0.05被认为是显著的。结果:87例心源性休克患者(60%为非裔美国人,67%为男性,平均年龄=62±15岁),其中54例(62%)死亡。死亡患者年龄较大,血压为bb0.1,院外骤停,入院24小时内骤停,SCAI分级、乳酸和ALT水平高于出院患者。logistic回归分析模型显示,年龄较大(RR=3.4 [95% CI: 3.3-3.45])、bbb1血压升高(RR=3.4 [95% CI: 2.6-4.2])和SCAI等级较高(2.1 [95% CI: 1.5-2.1],均P < 0.05)是心源性休克患者死亡率的独立预测因素。此外,在主要是非裔美国人研究人群中,大多数患者都有医疗保险或医疗补助保险。结论:心源性休克具有显著的死亡风险。高龄、使用一种以上的血管加压药物和较高的SCAI分级等因素已被确定为心源性休克住院患者死亡率的独立预测因素。此外,病情的进展和结果受到种族(例如,本研究中的非裔美国人)和经济挑战(包括保险覆盖类型(例如,医疗补助或医疗保险)等变量的影响。进一步的研究对于探索提高心源性休克患者存活率的策略至关重要,尤其要关注解决经济和种族差异。
{"title":"Burden and predictors of mortality related to cardiogenic shock in the South Bronx Population.","authors":"Nismat Javed, Vikram Itare, Sai Vishnu Vardhan Allu, Shalini Penikilapate, Neelanjana Pandey, Nisha Ali, Preeti Jadhav, Sridhar Chilimuri, Jonathan N Bella","doi":"10.62347/HYCA6457","DOIUrl":"10.62347/HYCA6457","url":null,"abstract":"<p><strong>Objectives: </strong>Cardiogenic shock is a significant economic burden on healthcare facilities and patients. The prevalence and outcome of cardiogenic shock in the South Bronx are unknown. The aim of the study was to examine the burden of non-AMI CS in Hispanic and Black population in South Bronx and characterize their in-hospital outcomes.</p><p><strong>Methods: </strong>We reviewed patient charts between 1/1/2022 and 1/1/2023 to identify patients with a primary diagnosis of cardiogenic shock (ICD codes R57.0, R57, R57.8, R57.9) residing in the following zip codes: 10451-59 and 10463. Student's T-test was used to assess differences for continuous variables; chi-square statistic was used for categorical variables. A logistic regression analysis model was used to assess independent predictors of mortality. A <i>P</i>-value of < 0.05 was considered significant.</p><p><strong>Results: </strong>87 patients were admitted with cardiogenic shock (60% African American, 67% male, mean age =62±15 years) of which 54 patients (62%) died. Those who died were older, had > 1 pressor, out-of-hospital arrest, arrested within 24 hours of admission, and had higher SCAI class, lactate, and ALT levels than those who were discharged. The logistic regression analysis model showed that older age ((RR=3.4 [95% CI: 3.3-3.45]), > 1 pressor (RR=3.4 [95% CI: 2.6-4.2]) and higher SCAI class (2.1 [95% CI: 1.5-2.1], all P < 0.05)) were independent predictors of mortality in patients with cardiogenic shock. Additionally, most of the patients had either Medicare or Medicaid insurance in predominantly African American study population.</p><p><strong>Conclusions: </strong>Cardiogenic shock carries a significant risk of death. Factors such as advanced age, the administration of more than one vasopressor, and a higher SCAI classification have been identified as independent predictors of mortality among inpatients with cardiogenic shock. Additionally, the progression and outcomes of the condition are influenced by variables like race (e.g., African American individuals in this study) and economic challenges, including the type of insurance coverage (e.g., Medicaid or Medicare). Further research is essential to explore strategies that could enhance survival rates in cardiogenic shock patients, with a particular focus on addressing economic and racial disparities.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"355-367"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of long-term outcomes in patients with cardiac sarcoidosis treated with different immunosuppressive drugs. 不同免疫抑制药物治疗心脏结节病的远期疗效比较。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/TSPL4520
Leighton A Hope, Timothy Chrusciel, Bilal Abuhaiba, Div Verma, Ravi Nayak, Mina M Benjamin

Background: We compared long-term clinical outcomes between patients with cardiac sarcoidosis (CS) who received no treatment (NT), steroid treatment (ST), disease-modifying anti-rheumatic drugs (DMARDs), or tumor necrosis factor alpha inhibitors (TNF).

Methods: Patients from SSM healthcare system's data warehouse were identified using ICD codes. Inclusion criteria included at least 6 months of follow-up. Outcomes studied were heart failure (HF) admissions, ventricular tachyarrhythmias (VTA), and pacemaker/defibrillator placement. Statistical analysis included multivariate logistic regression and Kaplan-Meier curves.

Results: We identified 198, 174, 66, and 19 patients in NT, ST, DMARDs, and TNF groups respectively. Mean age was 62.4, 60.2, 56, and 54.4 respectively. There was no significant difference in the rate of medical comorbidities including pulmonary sarcoidosis between the groups. Mean follow up was 92.3 months. Percent incidences of VTA were 17.5, 16.3, 12.5, and 5.6 (P 0.57) in the NT, ST, DMARDs and TNF groups respectively. DMARDs and TNF groups had a lower incidence of HF admission (43.9% and 36.8%) compared to NT and ST (59.1% and 59.2%). In the multivariate model, compared to NT group, the odds ratio for HF admission was 1.08 (CI: 0.70-1.65), 0.64 (0.36-1.14) and 0.45 (0.17-1.20) in the ST, DMARDs and TNF groups respectively. There was no significant difference in the rate of pacemaker/defibrillator placement between the groups.

Conclusion: In this retrospective study from a large healthcare system, CS patients treated with DMARDs or TNF had a trend for lower incidence of HF admission than those on NT or ST.

背景:我们比较了未接受治疗(NT)、类固醇治疗(ST)、改善疾病的抗风湿药物(DMARDs)或肿瘤坏死因子α抑制剂(TNF)的心脏结节病(CS)患者的长期临床结果。方法:采用ICD编码对SSM医疗保健系统数据仓库中的患者进行识别。纳入标准包括至少6个月的随访。研究结果包括心力衰竭(HF)入院、室性心动过速(VTA)和起搏器/除颤器放置。统计分析采用多元逻辑回归和Kaplan-Meier曲线。结果:我们分别在NT、ST、DMARDs和TNF组中鉴定了198、174、66和19例患者。平均年龄分别为62.4岁、60.2岁、56岁和54.4岁。两组间包括肺结节病在内的合并症发生率无显著差异。平均随访92.3个月。NT组、ST组、DMARDs组和TNF组VTA的发生率分别为17.5%、16.3%、12.5和5.6 (P 0.57)。与NT组和ST组(59.1%和59.2%)相比,dmard组和TNF组的HF入院发生率(43.9%和36.8%)较低。在多变量模型中,与NT组相比,ST组、DMARDs组和TNF组HF入院的优势比分别为1.08 (CI: 0.70-1.65)、0.64 (CI: 0.36-1.14)和0.45 (CI: 0.17-1.20)。两组间起搏器/除颤器放置率无显著差异。结论:在这项来自大型医疗系统的回顾性研究中,接受DMARDs或TNF治疗的CS患者比接受NT或ST治疗的患者HF入院发生率更低。
{"title":"Comparison of long-term outcomes in patients with cardiac sarcoidosis treated with different immunosuppressive drugs.","authors":"Leighton A Hope, Timothy Chrusciel, Bilal Abuhaiba, Div Verma, Ravi Nayak, Mina M Benjamin","doi":"10.62347/TSPL4520","DOIUrl":"10.62347/TSPL4520","url":null,"abstract":"<p><strong>Background: </strong>We compared long-term clinical outcomes between patients with cardiac sarcoidosis (CS) who received no treatment (NT), steroid treatment (ST), disease-modifying anti-rheumatic drugs (DMARDs), or tumor necrosis factor alpha inhibitors (TNF).</p><p><strong>Methods: </strong>Patients from SSM healthcare system's data warehouse were identified using ICD codes. Inclusion criteria included at least 6 months of follow-up. Outcomes studied were heart failure (HF) admissions, ventricular tachyarrhythmias (VTA), and pacemaker/defibrillator placement. Statistical analysis included multivariate logistic regression and Kaplan-Meier curves.</p><p><strong>Results: </strong>We identified 198, 174, 66, and 19 patients in NT, ST, DMARDs, and TNF groups respectively. Mean age was 62.4, 60.2, 56, and 54.4 respectively. There was no significant difference in the rate of medical comorbidities including pulmonary sarcoidosis between the groups. Mean follow up was 92.3 months. Percent incidences of VTA were 17.5, 16.3, 12.5, and 5.6 (P 0.57) in the NT, ST, DMARDs and TNF groups respectively. DMARDs and TNF groups had a lower incidence of HF admission (43.9% and 36.8%) compared to NT and ST (59.1% and 59.2%). In the multivariate model, compared to NT group, the odds ratio for HF admission was 1.08 (CI: 0.70-1.65), 0.64 (0.36-1.14) and 0.45 (0.17-1.20) in the ST, DMARDs and TNF groups respectively. There was no significant difference in the rate of pacemaker/defibrillator placement between the groups.</p><p><strong>Conclusion: </strong>In this retrospective study from a large healthcare system, CS patients treated with DMARDs or TNF had a trend for lower incidence of HF admission than those on NT or ST.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"342-354"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of cardiovascular disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1